BioCentury
ARTICLE | Clinical News

Antagonist G peptide: PTD began a Phase I Australian trial with Antagonist G

April 22, 1996 7:00 AM UTC

Peptide Technology Ltd. (Aus: PTD), Dee Why, Australia Product: Antagonist G peptide Indication: Cancer Status: PTD began a 20-patient Phase I Australian trial with Antagonist G, a second-generation d...